Dacarbazine
![](/Images/godic/202501/07/Dacarbazine.svg1159.png")
![Shealy et al., J. Org. Chem. 27, 2150 (1962); Hano et al., Gann 59, 207 (1968), C.A. 69, 42527g (1968).](/Images/godic/202501/07/Dacarbazine-synthesis.svg1159.png")
![](/Images/godic/202501/07/Dacarbazine_Formula_V.1.svg1159.png")
![](/Images/godic/202501/07/Dacarbazine_ball-and-stick1159.png")
Dacarbazine (brand names DTIC, DTIC-Dome; also known as DIC or imidazole carboxamide) is an antineoplastic chemotherapy drug used in the treatment of various cancers, among them malignant melanoma, Hodgkin's lymphoma, sarcoma, and islet cell carcinoma of the pancreas.